Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cancer Pain × Cognitive Behavioral Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sleep Initiation and Maintenance Disorders 28 Neoplasms 20 Breast Neoplasms 18 Depression 10 Anxiety Disorders 10 Prostatic Neoplasms 8 Fatigue 8 Lung Neoplasms 5 Motor Activity 4 Lymphoma 4 Weight Loss 3 Melanoma 3 Chronic Pain 3 Smoking Cessation 2 Sleep Wake Disorders 2 Pain 2 Overweight 2 Obesity 2 Nervous System Diseases 2 Multiple Myeloma 2 Glioma 2 Glioblastoma 2 Cognitive Dysfunction 2 Carcinoma, Non-Small-Cell Lung 2 Weight Gain 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Tobacco Use Disorder 1 Substance-Related Disorders 1 Stress, Psychological 1

Interventions

Morphine 15 Oxycodone 12 Fentanyl 7 Methadone 5 Lidocaine 5 Acetaminophen 5 resiniferatoxin 4 nabiximols 4 Ethanol 4 Transcutaneous Electric Nerve Stimulation 3 Acupuncture Therapy 3 Transcranial Direct Current Stimulation 2 Surveys and Questionnaires 2 Standard of Care 2 Sodium Bicarbonate 2 Radiofrequency Ablation 2 Pharmaceutical Services 2 Naloxone 2 Ketamine 2 Hydromorphone 2 Control Groups 2 Buprenorphine 2 Analgesics, Opioid 2 tanezumab 1 rofecoxib 1 naloxegol 1 incobotulinumtoxinA 1 fulranumab 1 cannabichromene 1 alvimopan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05774197 2025-11-04

STAMP+CBT

University of Oklahoma

Phase NA Completed

52 enrolled 7 charts

Cancer Pain, Color Vision Defects

Data powered by HemOnc (CC BY 4.0) Colophon ⚡